Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

Patients with RSV hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

These real-world results support the effectiveness of maternal RSV vaccination and could influence policy decisions in other ...

The delayed meeting of the CDC's main vaccines advisory committee has taken place, with new recommendations on respiratory syncytial virus (RSV ... where there is an outbreak of the disease.